or Try an Advanced Search...

    Seasonal Influenza Stocks List

    Symbol Grade Name % Change
    BCRX D BioCryst Pharmaceuticals, Inc. 18.43
    IBIO B iBio, Inc. 0.00
    IVVD F Invivyd, Inc. -2.48
    NVAX D Novavax, Inc. -3.45
    VXRT F Vaxart, Inc. 5.12
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Influenza Biopharmaceutical Biotechnology Coronavirus Medicine Vaccination Vaccines Angioedema Biology Disease Hereditary Angioedema Human Papilloma Virus Influenza Vaccine Viruses Acetamides Anthrax Antibodies Antibody Avian Influenza Biodefense

    Related ETFs - A few ETFs which own one or more of the above listed Seasonal Influenza stocks.

    Symbol Grade Name Weight
    GERM C ETFMG Treatments Testing and Advancements ETF 4.03
    XBI D SPDR S&P Biotech ETF 1.8
    IDNA C iShares Genomics Immunology and Healthcare ETF 1.68
    BBP C BioShares Biotechnology Products Fund 1.38
    LABU D Direxion Daily S&P Biotech Bull 3X Shares 1.09
    View all Seasonal Influenza ETFs...
    Compare ETFs
    Compare GERM to BBP Compare IDNA to LABU Compare XBI to BBP

        Seasonal Influenza Stocks Recent News

        Date Stock Title
        May 6 NVAX Novavax stock breaks six-day winning streak
        May 6 NVAX UPDATE 5-Shah Capital urges Novavax shareholders to vote against three directors
        May 6 BCRX BioCryst Pharmaceuticals, Inc. (BCRX) Q1 2024 Earnings Call Transcript
        May 6 BCRX BioCryst surges 18% on quarterly earnings, adjusted guidance outlook
        May 6 BCRX BioCryst Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation
        May 6 BCRX BioCryst Pharmaceuticals Reports Strong Q1 2024 Results, Exceeding Analyst Revenue Forecasts
        May 6 NVAX Novavax's top shareholder Shah Capital ramps up efforts for board shakeup
        May 6 BCRX BioCryst Pharmaceuticals (BCRX) Reports Q1 Loss, Tops Revenue Estimates
        May 6 BCRX BioCryst Pharmaceuticals beats top-line and bottom-line estimates; updates FY24 outlook
        May 6 BCRX BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update
        May 6 NVAX UPDATE 2-Novavax's top shareholder Shah Capital ramps up efforts for board shakeup
        May 6 NVAX Shah Capital Launches Campaign Urging Stockholders to Vote AGAINST the Re-Election of All of Novavax’s Directors Up for Election at its 2024 Annual Meeting
        May 3 BCRX BioCryst Pharmaceuticals Q1 2024 Earnings Preview
        May 2 IVVD Invivyd to Host Conference Call Discussing First Quarter 2024 Financial Results and Business Highlights
        May 1 NVAX How Is The Market Feeling About Novavax?
        Apr 30 NVAX Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know
        Apr 30 IVVD Invivyd cuts 14 positions, expects to end 2024 with at least $75M in cash
        Apr 30 BCRX Will Heron Therapeutics (HRTX) Report Negative Earnings Next Week? What You Should Know
        Apr 30 VXRT Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers
        Apr 30 IVVD Invivyd Announces $20 Million to $25 Million Improvement in Projected 2024 Year-End Cash Position
        Related Industries: Biotechnology
        Related Stock Lists: Influenza Biopharmaceutical Biotechnology Coronavirus Medicine Vaccination Vaccines Angioedema Biology Disease Hereditary Angioedema Human Papilloma Virus Influenza Vaccine Viruses Acetamides Anthrax Antibodies Antibody Avian Influenza Biodefense
        Seasonal Influenza

        Seasonal influenza, also known as the flu, is a contagious respiratory illness caused by influenza viruses. It can cause mild to severe illness, and at times can lead to death. Symptoms can include fever, cough, sore throat, runny or stuffy nose, body aches, headache, chills, and fatigue.

        Browse All Tags